Hydroxychloroquine Sulfate Tablet, Film Coated
Product Images NDC 55154-2074

2 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydroxychloroquine Sulfate (NDC 55154-2074). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4d47da53 Ac21 4acc B39b 413e3f26c7f7 01

4d47da53 Ac21 4acc B39b 413e3f26c7f7 01
Chemical structure of hydroxychloroquine sulfate shown as a molecular diagram with labeled substituents including a chlorine atom and a sulfate group (H2SO4).*
FDA Label Image

A9ae8704 Fde0 4609 9155 23c3cd4554f7 00

A9ae8704 Fde0 4609 9155 23c3cd4554f7 00
Hydroxychloroquine sulfate tablets USP 200 mg film-coated oral tablet, package containing 10 tablets. The label includes storage instructions, prescription-only status, and warnings about child-resistant packaging and sensitivity of children to the medication. Distributed by Cardinal Health 107, LLC, labeled with NDC 55154-2074-0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.